Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.

Mara J. Urshel

PubMed · 1968 · 75 citations · 0 references

Concepts

Abstract

The uptake and phosphorylation of 1-β-d-arabinofuranosylcytosine (ara-C) and related nucleosides was studied in ascitic leukemia L1210 and in a subline resistant to ara-C. Entry of ara-C into the ascites cells was rapid and led to equal intracellular and extracellular concentrations of the nucleoside in the resistant subline and, when deoxycytidine was present, in the parent line. Net uptake of free nucleoside was observed with deoxycytidine and cytidine but not with ara-C. The excess of intracellular over extracellular ara-C, which accumulated during incubation, consisted of phosphate esters, mainly the triphosphate (ara-CTP). Phosphorylation of both ara-C and deoxycytidine was decreased by over 97% in the resistant subline, but that of cytidine and deoxythymidine was unchanged from the level of the parent line. Deoxycytidine in 20-fold excess inhibited phosphorylation of ara-C in the parent L1210 cells by 99%; cytidine and deoxythymidine had only minor effects. Phosphorylation of deoxycytidine was only slightly affected by ara-C. The main products of deoxycytidine metabolism in the cells were its triphosphate and that of deoxythymidine. Administration of ara-C to mice bearing the parent leukemia L1210 also led to intracellular accumulation of ara-CTP and smaller amounts of the mono- and diphosphate. Prior administration of deoxycytidine decreased this accumulation by over 90%. A minor portion of the ara-C injected s.c. was present in the ascitic fluid as the deamination product, which was phosphorylated in the cells to a lesser extent than ara-C. It is concluded that phosphorylation of ara-C is mediated by deoxycytidine kinase, and that the drastic decrease in the activity of this enzyme is responsible for resistance to the drug. Deoxycytidine reverses the effect of ara-C by inhibiting its phosphorylation.